- Home
- BEAT vs FORA Comparison
BEAT vs FORA Comparison
Compare BEAT & FORA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- FORA
- Stock Information
- Founded
- BEAT 2015
- FORA 2014
- Country
- BEAT United States
- FORA United States
- Employees
- BEAT N/A
- FORA N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- FORA Computer Software: Prepackaged Software
- Sector
- BEAT Technology
- FORA Technology
- Exchange
- BEAT Nasdaq
- FORA Nasdaq
- Market Cap
- BEAT 65.1M
- FORA 77.6M
- IPO Year
- BEAT 2021
- FORA N/A
- Fundamental
- Price
- BEAT $2.08
- FORA $2.41
- Analyst Decision
- BEAT Buy
- FORA Strong Buy
- Analyst Count
- BEAT 1
- FORA 1
- Target Price
- BEAT $8.00
- FORA $5.00
- AVG Volume (30 Days)
- BEAT 131.3K
- FORA 55.9K
- Earning Date
- BEAT 03-19-2025
- FORA 03-27-2025
- Dividend Yield
- BEAT N/A
- FORA N/A
- EPS Growth
- BEAT N/A
- FORA N/A
- EPS
- BEAT N/A
- FORA N/A
- Revenue
- BEAT N/A
- FORA $19,709,723.00
- Revenue This Year
- BEAT N/A
- FORA N/A
- Revenue Next Year
- BEAT N/A
- FORA $13.59
- P/E Ratio
- BEAT N/A
- FORA N/A
- Revenue Growth
- BEAT N/A
- FORA N/A
- 52 Week Low
- BEAT $1.35
- FORA $1.96
- 52 Week High
- BEAT $3.48
- FORA $4.15
- Technical
- Relative Strength Index (RSI)
- BEAT 39.34
- FORA 48.34
- Support Level
- BEAT $2.05
- FORA $2.35
- Resistance Level
- BEAT $2.37
- FORA $4.03
- Average True Range (ATR)
- BEAT 0.18
- FORA 0.45
- MACD
- BEAT -0.02
- FORA -0.01
- Stochastic Oscillator
- BEAT 21.24
- FORA 19.00
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About FORA Forian Inc.
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.